World Vaccine Congress 2025

Anne Kasmar, M.D., M.Sc.

Senior Vice President, Global Therapeutic Area Head, Infectious Disease & Vaccines

Wednesday, April 23 from 12:40 - 1:10p.m.
Title – "Launching & leading successful vaccine studies: the essential role of Parexel’s site alliance network"
This presentation will highlight how our strong site alliance network accelerates start-up, and streamlines conduct of vaccine trials, leading to fast and efficient study execution.

• Parexel's Site Alliance Network includes over 350 alliance institutions and 21,000+ site investigators across 27 countries
• Key benefits for sites include assignment of a dedicated alliance manager and contract lead, as well as one-time negotiation of a master service agreement
• Key benefits for sponsors include active, early engagement that optimizes participant recruitment and retention while ensuring patient-centered study design

Adriana Suenaga

Senior Director, Integrated Solutions Strategy, Parexel

Tuesday, April 22 from 12:40 - 1:20p.m.
Title – "Essential insights from sites: leveraging learnings from Parexel’s vaccine alliance network”

This roundtable discussion will focus on best practices developed by Parexel’s site alliance network to optimize patient recruitment and retention, keeping participants at the heart of all we do.

Discuss strategies that led to the enrollment of approximately 75,000 participants in three ongoing pivotal Phase III programs, including Parexel's dedicated alliance manager system and quarterly pulse forums

Jay Liberman

Senior Medical Director

Tuesday, April 22 from 12:40 - 1:20p.m.
Title – "Essential insights from sites: leveraging learnings from Parexel’s vaccine alliance network”

This roundtable discussion will focus on best practices developed by Parexel’s site alliance network to optimize patient recruitment and retention, keeping participants at the heart of all we do.

Discuss strategies that led to the enrollment of approximately 75,000 participants in three ongoing pivotal Phase III programs, including Parexel's dedicated alliance manager system and quarterly pulse forums

Taylor Craig

Associate Director, Strategic Feasibility

Tuesday, April 22 from 12:40 - 1:20p.m.
Title – "Essential insights from sites: leveraging learnings from Parexel’s vaccine alliance network”

This roundtable discussion will focus on best practices developed by Parexel’s site alliance network to optimize patient recruitment and retention, keeping participants at the heart of all we do.

Discuss strategies that led to the enrollment of approximately 75,000 participants in three ongoing pivotal Phase III programs, including Parexel's dedicated alliance manager system and quarterly pulse forums

Cheri Savercool

Associate Director, Site Alliances, Therapeutic Networks

Tuesday, April 22 from 12:40 - 1:20p.m.
Title – "Essential insights from sites: leveraging learnings from Parexel’s vaccine alliance network”

This roundtable discussion will focus on best practices developed by Parexel’s site alliance network to optimize patient recruitment and retention, keeping participants at the heart of all we do.

Discuss strategies that led to the enrollment of approximately 75,000 participants in three ongoing pivotal Phase III programs, including Parexel's dedicated alliance manager system and quarterly pulse forums